abstract |
The present invention is an unsubstituted or substituted, (C 3 -8) cycloalkyl, (C 1-4) alkyl (C 3-8) cycloalkyl, (C 6 -18) aryl or (C 6 -18) aryl ( C 1-4 ) 3,4-dihydro-benzo [e] [1,3] oxazin-2-ones substituted at the nitrogen atom by alkyl and their use as pharmaceuticals.n n n MIF-Inhibitors, MIF Mediated Diseases |